FINHUB Insights

SYK · Q2 FY26 · Apr 1 – Jun 30, 2026

Stryker Q2 FY26: where the revenue came from and where it went

Stryker Q2 FY26: revenue $6.6B (+9% year over year). Net profit $1.3B. Largest cohort Med surg & neurotechnology $3.6B. The whole income statement as a sankey diagram from the SEC filing.

Period
Apr 1 – Jun 30, 2026
Reported
Jul 31, 2026 10-Q
Sankey diagram of Stryker's income statement for Q2 FY26: revenue of $6.59 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$6.59B +9% year over year
Gross profit$4.50B 68% margin
Operating profit$1.66B 25% margin
Net profit$1.28B 19% margin

The numbers

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 30, 2026).
ItemValueShare of revenueYear over year
Revenue 6.59 100% +9%
Med surg & neurotechnology 3.63 55% +10%
Orthopaedics & spine 2.96 45% +9%
Cost of revenue−2.0932%
Gross profit4.5068% margin+4pp
R&D−0.437%+0pp
SG&A−2.2334%−1pp
Other−0.183%+0pp
Operating profit1.6625% margin+7pp
Tax−0.29
Interest & other costs−0.10
Net profit1.2819%+5pp
Filing on EDGAR More quarters of SYK

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters